DEPACON vs ZONISADE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. DEPACON and ZONISADE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPACON	ZONISADE
Rating	72/100	70/100
Pharmacy pays	—	~$3.16 /30
Type	RX	RX
Active ingredient	VALPROATE SODIUM	ZONISAMIDE
Manufacturer	Abbvie	Azurity
Dosage forms	Injectable	Suspension
Drug class	Anti-Epileptic Agent	Anti-Epileptic Agent
Boxed warning	None	None
Half-life	about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)	—
Treats	—	Partial Epilepsies

depacon zonisade

Rating

72/100

70/100

Pharmacy pays

—

~$3.16 /30

Type

Active ingredient

VALPROATE SODIUM

ZONISAMIDE

Manufacturer

Abbvie

Azurity

Dosage forms

Injectable

Suspension

Drug class

Anti-Epileptic Agent

Boxed warning

None

Half-life

about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)

—

Treats

—

Partial Epilepsies

Frequently asked questions

Which is better-rated, Depacon or Zonisade?

By our independent rating, Depacon scores higher — 3.6 vs 3.5 out of 5 for Zonisade. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depacon and Zonisade?

Depacon contains Valproate Sodium, while Zonisade contains Zonisamide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.